Routine Neutral

2026-11-05 19:59

- Zensar Technologies Limited informed about the allotment of 31,440 equity shares of Rs. 2/- each against the exercise of ESOPs on November 05, 2026. - Consequent to the allotment, the issued and subscribed share capital increased to Rs. 455,549,544 divided into 227,774,772 equity shares.

Governance Neutral

2026-11-05 19:57

- Zensar Technologies announced the allotment of 31,440 fully paid-up equity shares of face value ₹2 each under the Employee Stock Option Plan (ESOP). - The allotment was approved by the Nomination and Remuneration Committee on November 5, 2026. - Post-allotment, the company's issued and subscribed share capital increased to ₹455,549,544, consisting of 227,774,772 equity shares.

Business Update Neutral

2026-11-04 18:59

- Zensar Technologies has made available the transcript of the Q2FY27 earnings call held on October 29, 2026. - The transcript is accessible on the company's website under the investor section.

Business Update Neutral

2026-11-04 18:57

- Earnings call transcript for Q2FY27 financial results held on October 29, 2026, made available on the company's website.

Business Update Neutral

2026-10-29 17:29

- Zensar Technologies Limited has made available the audio recording of the Q2FY27 results earnings call held on October 29, 2026. - The earnings call discussed the financial results of the company for the quarter ended September 30, 2026. - The audio recording can be accessed on the company's website under the Investor Corner section.

Business Update Neutral

2026-10-29 17:18

- Zensar Technologies Limited has submitted the audio recording link for the Q2FY27 Results Earnings Call held on October 29, 2026. - The recording is accessible on the company's website under the Investor Corner and Earnings Call Recording section.

Financials Positive

2026-10-28 22:38

Q2 FY27 Consolidated Revenue ₹15,852Mn vs ₹14,213Mn (▲11.5% YoY) EBITDA ₹2,497Mn vs ₹2,200Mn (▲13.5% YoY) PAT ₹1,902Mn vs ₹1,822Mn (▲4.3% YoY) EBITDA Margin 15.8% vs 15.5% (▲30bps)

Financials Positive

2026-10-28 22:38

Q2 FY27 Consolidated Revenue ₹15,852Cr vs ₹14,213Cr (▲11.5% YoY) EBITDA ₹2,497Cr vs ₹2,200Cr (▲13.5% YoY) PAT ₹1,902Cr vs ₹1,822Cr (▲4.3% YoY) EBITDA Margin 15.8% vs 15.5% (▲30bps)

Business Update Positive

2026-10-28 22:36

- Zensar Technologies Board approved the Scheme of Amalgamation of its wholly-owned subsidiary, M3bi India Private Limited, with itself. - The amalgamation aims to achieve business synergies, higher operational efficiencies, and unified control. - Since M3bi is a wholly-owned subsidiary, no shares will be issued and no consideration will be paid. - The scheme is subject to NCLT and other regulatory approvals.

Financials Positive

2026-10-28 22:36

Q2 FY27 Consolidated Revenue ₹15,852Cr vs ₹14,213Cr (▲11.5% YoY) EBITDA ₹2,497Cr vs ₹2,200Cr (▲13.5% YoY) PAT ₹1,902Cr vs ₹1,822Cr (▲4.3% YoY) EBITDA Margin 15.8% vs 15.5% (▲30bps)

Financials Positive

2026-10-28 22:36

Q2 FY27 Consolidated Revenue ₹15,852Mn vs ₹14,213Mn (▲11.5% YoY) EBITDA ₹2,497Mn vs ₹2,200Mn (▲13.5% YoY) PAT ₹1,902Mn vs ₹1,822Mn (▲4.3% YoY) EBITDA Margin 15.8% vs 15.5% (▲30bps)

Business Update Positive

2026-10-28 22:29

- Zensar Technologies Limited has approved the Scheme of Amalgamation of its wholly owned subsidiary, M3bi India Private Limited, with itself. - The amalgamation aims to achieve greater business synergies, higher operational efficiencies, and unified control. - No shares or cash consideration will be issued since M3bi is a wholly owned subsidiary. - The transaction is subject to NCLT and regulatory approvals.

Financials Neutral

2026-10-28 22:28

Q2 FY27 Consolidated Revenue ₹1,585.2 Cr vs ₹1,421.3 Cr (▲11.5% YoY) EBITDA ₹249.7 Cr vs ₹210.0 Cr (▲18.9% YoY) PAT ₹190.2 Cr vs ₹182.2 Cr (▲4.4% YoY) EBITDA Margin 15.8% vs 14.8% (▲100bps)

Financials Neutral

2026-10-28 22:20

Q2 FY27 Consolidated Revenue ₹1,585 Cr vs ₹1,421 Cr (▲12% YoY) EBITDA ₹250 Cr vs ₹210 Cr (▲19% YoY) PAT ₹190 Cr vs ₹182 Cr (▲4% YoY) EBITDA Margin 15.8% vs 14.8% (▲100bps)

Financials Neutral

2026-10-28 22:18

Q2 FY27 Consolidated Revenue ₹1,585.2 Cr vs ₹1,421.3 Cr (▲11.5% YoY) EBITDA ₹249.7 Cr vs ₹210.0 Cr (▲18.9% YoY) PAT ₹190.2 Cr vs ₹182.2 Cr (▲4.4% YoY) EBITDA Margin 15.8% vs 14.8% (▲98bps)

Business Update Positive

2026-10-19 19:27

- Zensar Technologies received an independent ESG Report and overall rating from NSE Sustainability Ratings and Analytics Limited on October 15, 2026. - The company was assigned an overall ESG rating of 76, placing it in the "Leader" category for FY2026 based on public domain information. - The rating agency confirmed the assigned score on October 19, 2026, after reviewing the company's representation and observations.

Business Update Positive

2026-10-19 19:25

- Zensar Technologies received an independent ESG Report from NSE Sustainability Ratings and Analytics Limited on October 15, 2026. - The Rating Agency assigned an overall ESG Rating of 76, placing the company under the "Leader" category for FY2026. - The rating was unsolicited and based on publicly available information, with the agency confirming the assigned score after reviewing company representations.

Business Update Neutral

2026-10-14 16:33

Concall Schedule Concall Date: October 29, 2026 Concall Time: 8:30 am (IST)

Business Update Neutral

2026-10-14 16:27

Concall Schedule Concall Date: October 29, 2026 Concall Time: 8:30 am (IST)

Governance Neutral

2026-10-07 16:29

- Zensar Technologies Limited has announced the allotment of 162,619 fully paid equity shares of Rs. 2/- each to employees upon the exercise of ESOPs. - The allotment was approved by the Nomination and Remuneration Committee on October 07, 2026. - Post allotment, the issued and subscribed share capital increased to Rs. 455,486,664 consisting of 227,743,332 equity shares of Rs. 2/- each.

Routine Neutral

2026-10-07 16:13

- Zensar Technologies announced the allotment of 162,619 fully paid equity shares of Rs. 2/- each on October 07, 2026, pursuant to the exercise of ESOPs by employees. - Consequently, the issued and subscribed share capital of the company increased to Rs. 455,486,664 divided into 227,743,332 equity shares.

Governance Neutral

2026-10-07 16:09

- Board meeting scheduled on Wednesday, October 28, 2026. - Agenda to consider and approve Q2 and H1 FY2026-27 unaudited standalone and consolidated financial results. - Trading window closed from October 1, 2026, until 48 hours post result declaration.

Business Update Positive

2026-08-31 16:53

- ICRA Limited re-affirmed Zensar Technologies Limited's credit rating for Long Term/Short Term-Fund Based/Non-Fund Based as [ICRA]AA+ (Stable)/[ICRA]A1+. The total rated amount is ₹191.00 Crore.

Business Update Positive

2026-08-31 16:52

- Zensar Technologies Limited's credit rating re-affirmed by ICRA Limited. - Long Term/Short Term-Fund Based/Non-Fund Based rating maintained at [ICRA]AA+ (Stable)/[ICRA]A1+. - Total rated amount of ₹191.00 Crore.

Ownership Neutral

2026-08-24 19:26

- On August 24, 2026, the Nomination and Remuneration Committee approved the allotment of 25,691 equity shares of Rs. 2/- each to employees upon the exercise of ESOPs. - The issued and subscribed share capital increased to Rs. 455,161,426, comprising 227,580,713 equity shares.

Ownership Neutral

2026-08-24 19:16

- On August 24, 2026, Zensar Technologies allotted 25,691 equity shares of ₹2/- each to employees upon the exercise of ESOPs. - The issued and subscribed share capital of the company increased to 227,580,713 equity shares of ₹2/- each.

Business Update Positive

2026-08-14 13:19

- Zensar completed requisite filings for the merger of its US-based 100% step-down subsidiaries, M3BI LLC and Bridgeview Life Sciences LLC, with Zensar Technologies Inc., USA. The merger of M3BI LLC will be effective from September 1, 2026.

Business Update Positive

2026-08-14 13:18

- Zensar Technologies announced the completion of requisite filings for the merger of its US subsidiaries, Bridgeview Life Sciences LLC and M3BI LLC, with Zensar Technologies Inc., USA. - The merger of M3BI LLC will be effective from September 1, 2026.

Business Update Neutral

2026-08-10 13:47

- Investor Meeting Schedule - Date: August 13, 2026, Time: 1:00 p.m. onwards, Event: Equirus Annual India Conference 2026 (In Person Group Meeting) - Date: August 14, 2026, Time: 10:00 a.m. onwards, Event: Emkay Confluence 2026 – India: Full Throttle Ahead

Business Update Neutral

2026-08-10 13:38

- Concall Schedule - August 13, 2026: Equirus Annual India Conference 2026 (Group Meeting, In Person from 1:00 p.m. onwards) - August 14, 2026: Emkay Confluence 2026 – India: Full Throttle Ahead (from 10:00 a.m. onwards)

Business Update Neutral

2026-08-10 13:31

- Concall Schedule - August 13, 2026, 1:00 p.m. onwards: Equirus Annual India Conference 2026 (In Person Group Meeting) - August 14, 2026, 10:00 a.m. onwards: Emkay Confluence 2026 – India: Full Throttle Ahead (In Person Group Meeting) - No unpublished price sensitive information will be shared during these meetings.

Business Update Neutral

2026-08-10 13:29

- Zensar Technologies Limited will participate in investor meetings as per the following schedule: - Investor Meeting 1: Equirus Annual India Conference 2026 - Date: August 13, 2026 - Time: 1:00 p.m. onwards - Investor Meeting 2: Emkay Confluence 2026 – India: Full Throttle Ahead - Date: August 14, 2026 - Time: 10:00 a.m. onwards - No unpublished price sensitive information will be shared during these meetings.

Business Update Positive

2026-08-08 14:19

- Crisil assigned Zensar Technologies an overall ESG Score of 74 under the 'Leadership' category for FY26. - The rating reflects the Company's strong performance on ESG parameters.

Business Update Positive

2026-08-08 14:16

- Zensar Technologies Limited received an overall ESG Score of 74 from Crisil ESG Ratings & Analytics Limited for fiscal year 2026. This places the company in the 'Leadership' category for its ESG performance.

Business Update Neutral

2026-08-05 20:59

- Earnings Call Transcript for Q1FY27 results made available on the company website. - The call was held on July 30, 2026, discussing financial results for the quarter ended June 30, 2026.

Business Update Neutral

2026-08-05 20:59

- Earnings Call Transcript for Q1FY27 results, held on July 30, 2026, is now available. - The transcript can be accessed on Zensar Technologies' investor relations website.

Governance Positive

2026-07-31 17:44

- The 63rd Annual General Meeting (AGM) held on July 30, 2026, passed all resolutions with requisite majority. - This included approving FY26 financials, confirming an interim dividend of ₹2.40 and declaring a final dividend of ₹12.60 per share for FY26. - Re-appointment of H. V. Goenka and approval of ₹7,500 million Material Related Party Transactions for FY27 were also passed.

Governance Neutral

2026-07-31 17:43

- Zensar Technologies Limited submitted the voting results and Scrutinizer's Report for its 63rd Annual General Meeting (AGM) held on July 30, 2026. - All resolutions transacted at the AGM were passed with the requisite majority. - Resolutions passed include adoption of financial statements for FY26, declaration of final dividend of INR 12.60/share, re-appointment of H. V. Goenka as Director, and approval of material related party transactions.

Business Update Neutral

2026-07-31 14:51

- Filings for the merger of Bridgeview Life Sciences LLC with Zensar Technologies Inc. (USA) are complete. - This merger will be effective from August 1, 2026. - Filings for the merger of M3BI LLC with Zensar Technologies Inc. are currently in progress.

Business Update Neutral

2026-07-31 14:50

- Zensar Technologies completed filings for the merger of its US subsidiary Bridgeview Life Sciences LLC with Zensar Technologies Inc., effective August 1, 2026. - Filings for the merger of M3BI LLC with Zensar Technologies Inc. are currently in progress.

Governance Neutral

2026-07-30 17:24

- The 63rd Annual General Meeting (AGM) of Zensar Technologies Limited was held on July 30, 2026. - Members adopted the Audited Standalone and Consolidated Financial Statements for FY ended March 31, 2026. - Confirmed payment of Interim Dividend and declared Final Dividend. - Approved re-appointment of H. V. Goenka. - Approved Material Related Party Transactions of INR 7,500 Million for FY 2026-27.

Governance Neutral

2026-07-30 17:24

- The 63rd Annual General Meeting (AGM) of Zensar Technologies Limited was held on Thursday, July 30, 2026, at 3:30 P.M. (IST). - Key business conducted included adoption of FY26 financial statements, confirmation of interim dividend, declaration of final dividend, re-appointment of H. V. Goenka, and approval of material related party transactions worth INR 7,500 Million for FY27.

Business Update Neutral

2026-07-30 11:22

- Audio recording of the Q1FY27 Results Earnings Call, held on July 30, 2026, at 08:30 AM (IST), is now available on Zensar Technologies Limited's website under the 'Investors Corner' section.

Business Update Neutral

2026-07-30 11:21

- Audio recording of the Q1FY27 earnings call held on July 30, 2026, discussing financial results for the quarter ended June 30, 2026, has been made available on the company's website.

Business Update Positive

2026-07-29 20:31

- The Board approved in-principle the merger of US step-down subsidiaries, Bridgeview Life Sciences LLC and M3BI LLC, into Zensar Technologies Inc., USA. - This aims for greater business synergies, higher operational efficiencies, and unified control. - No change in the shareholding pattern of the listed entity.

Business Update Positive

2026-07-29 20:31

- Board accorded in-principle approval for the merger of two US-based step-down subsidiaries, Bridgeview Life Sciences LLC and M3BI LLC, into Zensar Technologies Inc., USA, a wholly-owned subsidiary. The merger aims to achieve greater business synergies and operational efficiencies. It will not change the listed entity's shareholding pattern.

Financials Neutral

2026-07-29 20:27

- Consolidated Revenue ₹15,083Mn vs ₹13,850Mn (▲8.9% YoY) - EBITDA ₹2,208Mn vs ₹2,106Mn (▲4.8% YoY) - PAT ₹1,838Mn vs ₹1,820Mn (▲1.0% YoY) - EBITDA Margin 14.6% vs 15.2% (▼60bps)

Financials Neutral

2026-07-29 20:26

- Consolidated Revenue ₹15,083 Mn vs ₹13,850 Mn (▲8.9% YoY) - EBITDA ₹2,208 Mn vs ₹2,106 Mn (▲4.9% YoY) - PAT ₹1,838 Mn vs ₹1,820 Mn (▲1.0% YoY) - EBITDA Margin 14.6% vs 15.2% (▼60bps)

Financials Neutral

2026-07-29 20:23

- Consolidated Revenue ₹15,083 Million vs ₹13,850 Million (▲8.90% YoY) - EBITDA ₹2,209 Million vs ₹2,106 Million (▲4.89% YoY) - PAT ₹1,838 Million vs ₹1,820 Million (▲0.99% YoY) - EBITDA Margin 14.65% vs 15.21% (▼56bps)

Financials Positive

2026-07-29 20:20

- Consolidated Revenue ₹1,508.3 Cr vs ₹1,385.0 Cr (▲8.9% YoY) - EBITDA ₹220.9 Cr vs ₹210.6 Cr (▲4.9% YoY) - PAT ₹183.8 Cr vs ₹182.0 Cr (▲1.0% YoY) - EBITDA Margin 14.6% vs 15.2% (▼60bps)

Financials Neutral

2026-07-29 20:16

- Consolidated Revenue ₹15,083Mn vs ₹13,850Mn (▲8.9% YoY) - EBITDA ₹2,209Mn vs ₹2,106Mn (▲4.9% YoY) - PAT ₹1,838Mn vs ₹1,820Mn (▲1.0% YoY) - EBITDA Margin 14.7% vs 15.2% (▼56bps)

Business Update Neutral

2026-07-27 10:02

- Concall Schedule - Concall Date: July 30, 2026 - Concall Time: 8:30 AM IST

Business Update Neutral

2026-07-27 10:01

- Concall Schedule - Concall Date: July 30, 2026 - Concall Time: 8:30 AM IST

Business Update Neutral

2026-07-24 18:59

- Zensar Technologies Limited has submitted a revised Integrated Annual Report for FY 2025-26 on July 24, 2026. - The revision was made to update the RPG Group Logo, which was not properly reflected in the previously submitted report dated July 8, 2026.

Governance Neutral

2026-07-21 16:30

- Board Meeting scheduled for July 29, 2026, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026 (Q1-FY2026-27). - Trading Window for dealing in securities is closed from July 1, 2026, and will open 48 hours post Q1-FY2026-27 Financial Results declaration.

Ownership Neutral

2026-07-20 22:02

- On July 20, 2026, the Nomination and Remuneration Committee approved the allotment of 21,130 fully paid equity shares of Rs. 2/- each to employees against the exercise of ESOPs. - Consequently, the issued and subscribed share capital increased to 227,555,022 equity shares of Rs. 2/- each.

Business Update Positive

2026-07-20 21:58

- Zensar Technologies granted 6,28,502 stock options to eligible employees under 'Zensar - Employees Stock Option Scheme 2025'. - The exercise price is ₹2 per option (face value). - The grant was approved by the Nomination and Remuneration Committee on July 20, 2026.

Ownership Positive

2026-07-20 21:43

- On July 20, 2026, the Nomination and Remuneration Committee allotted 21,130 equity shares of Rs. 2/- each to employees against the exercise of ESOPs. - This increased the issued and subscribed share capital to 227,555,022 equity shares of Rs. 2/- each.

Ownership Positive

2026-07-20 21:41

- Zensar Technologies granted 6,28,502 stock options to eligible employees under the 'Zensar - Employees Stock Option Scheme 2025' on July 20, 2026. - The exercise price for these options is ₹2/- per option.

Governance Neutral

2026-07-08 16:28

- The 63rd Annual General Meeting (AGM) of Zensar Technologies Limited is scheduled for Thursday, July 30, 2026, at 03:30 P.M. (IST) via Video Conference. - The Integrated Annual Report for FY2025-26 has been dispatched. - The Record date for Final Dividend is Friday, July 17, 2026. - Dividend payment is on or before August 29, 2026.

Governance Neutral

2026-07-08 16:25

- Zensar Technologies Limited informed about the 63rd Annual General Meeting (AGM) to be held on Thursday, July 30, 2026, at 3:30 P.M. (IST) via Video Conference/OAVM. - The Integrated Annual Report for FY2025-26 and AGM Notice have been dispatched and are accessible on the company's website and stock exchange websites. - The record date for the Final Dividend is July 17, 2026. - E-Voting will start on July 27, 2026, and end on July 29, 2026. - The dividend payment date is on or before August 29, 2026.

Business Update Negative

2026-07-08 16:17

CRITICAL RED FLAG DETECTED

- Zensar Technologies Limited filed its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. - The report details environmental, social, and governance initiatives, including a 56.5% reduction in Scope 1+2 emissions from FY23 baseline and an investment of INR 75.9 Mn in community development for FY26. - An Independent Director ceased to be a director on April 17, 2026.

Governance Neutral

2026-07-08 16:04

- Zensar Technologies Limited will hold its 63rd Annual General Meeting (AGM) on Thursday, July 30, 2026, at 03:30 P.M. (IST) via Video Conferencing (VC)/Other Audio Visual Means (OAVM). - The Integrated Annual Report for FY 2025-26, along with the Notice of the 63rd AGM and other Statutory Reports, has been submitted and is available on the company's website.

Governance Positive

2026-07-08 15:55

- Zensar Technologies Limited will hold its 63rd Annual General Meeting on Thursday, July 30, 2026, at 03:30 P.M. (IST) via Video Conferencing/OAVM. - Key agenda items include adoption of FY2025-26 accounts, declaration of a Final Dividend of INR 12.60 per equity share (totaling INR 15.00 with interim), re-appointment of H. V. Goneka, and approval of material related party transactions.

Governance Positive

2026-07-08 15:54

- The 63rd Annual General Meeting (AGM) of Zensar Technologies Limited will be held on Thursday, July 30, 2026, at 03:30 P.M. (IST) via Video Conferencing (VC)/Other Audio Visual Means (OAVM). - Agenda includes adoption of FY2025-26 financial statements, confirmation of Interim Dividend of ₹2.40 per equity share, and declaration of a Final Dividend of ₹12.60 per equity share for FY2025-26. - The record date for the final dividend is Friday, July 17, 2026. - Approval for Material Related Party Transactions worth ₹7,500 Million for FY2026-27 is also on the agenda.

Financials Positive

2026-06-30 16:40

- Intimation of 63rd AGM on July 30, 2026, at 3:30 P.M. (IST) via VC/OAVM. - Board recommended a final dividend of ₹12.60 per Equity share for FY26, subject to AGM approval. - Record Date for the final dividend is July 17, 2026.

Governance Positive

2026-06-30 16:32

- The 63rd Annual General Meeting (AGM) will be held on July 30, 2026, at 3:30 P.M. (IST). - A final dividend of Rs. 12.60 per equity share for FY2025-26 has been recommended. - The Record Date for the dividend is July 17, 2026.

Governance Positive

2026-06-30 16:20

- 63rd Annual General Meeting (AGM) to be held on Thursday, July 30, 2026, at 3:30 P.M. (IST) via Video Conferencing. - Board recommended a final dividend of Rs. 12.60/- per equity share for FY 2025-26, subject to AGM approval. - Record Date for the final dividend is Friday, July 17, 2026.

Governance Positive

2026-06-30 16:16

- Zensar Technologies announced its 63rd Annual General Meeting (AGM) on July 30, 2026, at 3:30 PM (IST). - The Board recommended a final dividend of Rs. 12.60/- per equity share for FY 2025-26. - The record date for the final dividend is Friday, July 17, 2026.

Routine Neutral

2026-06-29 16:05

- The trading window for dealing in the company's securities will close from July 1, 2026. - This closure is for Designated Persons ahead of the consideration of Unaudited Financial Results for the quarter ended June 30, 2026. - The window will reopen 48 hours after the results are declared.

Routine Neutral

2026-06-29 16:04

- Trading window closed from July 1, 2026, for designated persons to consider Unaudited Financial Results for the quarter ended June 30, 2026. - Window will reopen 48 hours after results declaration.

Ownership Positive

2026-06-16 19:11

- Nomination and Remuneration Committee approved allotment of 38,238 fully paid equity shares of Rs. 2/- each on June 16, 2026. - Shares allotted to employees against the exercise of ESOPs. - Consequently, the issued and subscribed share capital increased to 227,533,892 equity shares.

Ownership Positive

2026-06-16 19:00

- The Nomination and Remuneration Committee approved allotment of 38,238 fully paid equity shares of ₹2/- each to employees against ESOP exercise on June 16, 2026. - Consequently, the issued and subscribed share capital increased to 227,533,892 equity shares of ₹2/- each.

Governance Positive

2026-06-15 21:20

- Zensar Technologies Limited appointed Mr. Brahma Pandey as Senior Vice President, effective June 15, 2026. - Mr. Pandey brings over 25 years of experience in the global technology services industry, with a strong background in sales leadership and driving strategic growth.

Governance Positive

2026-06-15 21:17

- Zensar Technologies Limited announced the appointment of Mr. Brahma Pandey as Senior Vice President (Senior Management Personnel) with effect from June 15, 2026. - Mr. Pandey brings over 25 years of experience in the technology services industry, including his previous role as VP & Head of Sales at Infosys, with a focus on strategic growth.

Routine Neutral

2026-06-05 16:24

- Company intimates shareholders holding physical shares to update KYC details (PAN, contact, bank, signature) as per SEBI circulars (Feb 6, 2026 & Jun 10, 2024). - Failure to update may lead to dividend withholding. - Also part of 'Saksham Niveshak' campaign (Apr 1 - Jul 9, 2026) to claim unpaid dividends.

Routine Neutral

2026-05-29 13:09

Zensar Technologies Limited informed shareholders about the process for Tax Deduction at Source (TDS)/withholding tax on the final dividend of ₹12.60 per share recommended for FY 2025-26. Shareholders must submit required documents for tax exemption or lower withholding tax by June 26, 2026. The company also urged shareholders to update KYC and bank details for electronic dividend payments and highlighted the 'Saksham Niveshak' campaign from April 1 to July 9, 2026, to help claim unpaid dividends.

ZENSARTECH

Zensar Technologies Limited

Price Chart

Filing History

Unlock Full History